GENESIS- 0.015% triamcinolone acetonide spray

Երկիր: Ամերիկայի Միացյալ Նահանգներ

Լեզու: անգլերեն

Աղբյուրը: NLM (National Library of Medicine)

Ակտիվ բաղադրիչ:

TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA)

Հասանելի է:

Virbac AH, Inc.

INN (Միջազգային անվանումը):

TRIAMCINOLONE ACETONIDE

Կազմը:

TRIAMCINOLONE ACETONIDE 0.15 mg in 1 mL

Կառավարման երթուղին:

TOPICAL

Ռեկվիզորի տեսակը:

PRESCRIPTION

Թերապեւտիկ ցուցումներ:

GENESIS Topical Spray is indicated for the control of pruritus associated with allergic dermatitis in dogs.

Ապրանքի ամփոփագիր:

GENESIS Topical Spray is supplied in 8 ounce (237 mL) and 16 ounce (478 mL) bottles with spray applicators. For technical information or to report adverse reactions, please call 1-800-338-3659.

Լիազորման կարգավիճակը:

New Animal Drug Application

Ապրանքի հատկությունները

GENESIS- 0.015% TRIAMCINOLONE ACETONIDE SPRAY
VIRBAC AH, INC.
----------
GENESIS TOPICAL SPRAY
Approved by FDA under NADA # 141-210
GENESIS®
TOPICAL SPRAY
SOLUTION OF 0.015% TRIAMCINOLONE ACETONIDE
FOR TOPICAL USE IN DOGS ONLY
CAUTION: Federal law (USA) restricts this drug to use by or on the
order of a licensed
veterinarian.
DESCRIPTION
GENESIS® Topical Spray contains 0.015% triamcinolone acetonide for
dermatologic use.
Each mL of GENESIS Topical Spray contains 0.15 mg triamcinolone
acetonide in an
aqueous solution containing propylene glycol, specially denatured
alcohol, and DMDM
hydantoin.
PHARMACOLOGY
Triamcinolone acetonide is a highly potent synthetic glucocorticoid,
which is primarily
effective because of its anti-inflammatory activity. Topical
corticosteroids can be
absorbed from normal intact skin. Studies have demonstrated that
topical preparations
of triamcinolone have decreased plasma cortisol levels and suppressed
the response to
ACTH.
INDICATIONS
GENESIS Topical Spray is indicated for the control of pruritus
associated with allergic
dermatitis in dogs.
DOSAGE AND ADMINISTRATION
Apply suffcient pump sprays to uniformly and thoroughly wet the
affected areas while
avoiding run-off of excess product. Avoid getting the spray in dog’s
eyes. GENESIS
Topical Sprays should be administered twice daily for seven days, once
daily for the next
seven days, then every other day for an additional 14 days (28 days
total).
To avoid overdosing the product, use the following table to determine
the maximum
number of pump sprays per treatment application. For mild pruritus or
for small
treatment surface areas, the number of pumps used should be less than
this maximum
amount.
WARNINGS
User Safety: Wear gloves when applying the product. Spray in a well
ventilated area. If
the spray causes irritation to mucous membranes, discontinue use.
KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
Animal Safety: Clinical and experimental data have demonstrated that
corticosteroids
administered orally or by injection to animals may